Checkpoint Therapeutics Appoints Christian Béchon to its Board of Directors

NEW YORK, Oct. 16 (Korea Bizwire) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers, today announced that it has appointed Christian Béchon to its Board of Directors.  James F. Oliviero, President and Chief Executive Officer [...]